- Home
- FTFT vs PHIO Comparison
FTFT vs PHIO Comparison
Compare FTFT & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- PHIO
- Stock Information
- Founded
- FTFT N/A
- PHIO 2011
- Country
- FTFT United States
- PHIO United States
- Employees
- FTFT N/A
- PHIO N/A
- Industry
- FTFT Business Services
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- PHIO Health Care
- Exchange
- FTFT Nasdaq
- PHIO Nasdaq
- Market Cap
- FTFT 11.0M
- PHIO 10.2M
- IPO Year
- FTFT N/A
- PHIO N/A
- Fundamental
- Price
- FTFT $1.89
- PHIO $2.18
- Analyst Decision
- FTFT
- PHIO Strong Buy
- Analyst Count
- FTFT 0
- PHIO 3
- Target Price
- FTFT N/A
- PHIO $10.67
- AVG Volume (30 Days)
- FTFT 155.3K
- PHIO 2.7M
- Earning Date
- FTFT 08-26-2025
- PHIO 08-14-2025
- Dividend Yield
- FTFT N/A
- PHIO N/A
- EPS Growth
- FTFT N/A
- PHIO N/A
- EPS
- FTFT N/A
- PHIO N/A
- Revenue
- FTFT $2,031,913.00
- PHIO N/A
- Revenue This Year
- FTFT N/A
- PHIO N/A
- Revenue Next Year
- FTFT N/A
- PHIO N/A
- P/E Ratio
- FTFT N/A
- PHIO N/A
- Revenue Growth
- FTFT N/A
- PHIO N/A
- 52 Week Low
- FTFT $1.01
- PHIO $0.97
- 52 Week High
- FTFT $5.70
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- FTFT 46.86
- PHIO 40.77
- Support Level
- FTFT $1.52
- PHIO $2.03
- Resistance Level
- FTFT $1.96
- PHIO $2.29
- Average True Range (ATR)
- FTFT 0.24
- PHIO 0.16
- MACD
- FTFT -0.08
- PHIO -0.03
- Stochastic Oscillator
- FTFT 40.66
- PHIO 22.39
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.